The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil. (2018)

First Author: De Lemos LLP

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s40273-017-0579-0

PubMed Identifier: 29139001

Publication URI: http://europepmc.org/abstract/MED/29139001

Type: Journal Article/Review

Volume: 36

Parent Publication: PharmacoEconomics

Issue: 2

ISSN: 1170-7690